Indication
Refractory Seizures
1 clinical trial
2 products
Clinical trial
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Examine The Efficacy And Safety Of ZX008 In Subjects With CDKL5 Deficiency Disorder Followed By An Open-Label ExtensionStatus: Recruiting, Estimated PCD: 2025-02-05
Product
ZX008Product
Matching ZX008